Glycopyrrolate Injection, Solution
Product Images NDC 66794-204

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 66794-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glycopyrrolate Structure (Glycopyrrolate Str)

Chemical structure of glycopyrrolate showing its molecular arrangement including a quaternary ammonium group with associated bromide ion. The molecular formula C19H28BrNO3 and molecular weight 398.33 are noted below the structure.*

FDA Label Image

Piramal (Glycopyrrolate Fig9)

FDA Label Image

Vial 1 (Vial 1ml)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL, solution for injection. The label states that it contains benzyl alcohol, is for single dose vial use, and is for intramuscular or intravenous administration. Manufactured for Piramal Critical Care Inc., Bethlehem, PA, USA. Includes NDC, barcode, lot, and expiration date fields.*

FDA Label Image

Carton 1 (Carton 1ml)

Carton label for Glycopyrrolate Injection, USP 0.2 mg/mL in single dose vials. The label shows it is for intramuscular or intravenous administration and contains benzyl alcohol as a preservative. Manufactured by Piramal Critical Care Inc. The carton contains 25 vials of 1 mL each and includes storage instructions and caution that it is not for use in newborns.*

FDA Label Image

Vial 2 (Vial 2ml)

Packaging label for Glycopyrrolate Injection, USP with a strength of 0.4 mg/2 mL (0.2 mg/mL) in solution form. The label indicates single-dose vials of 2 mL each, containing benzyl alcohol as a preservative, for intramuscular or intravenous use. Manufactured for Piramal Critical Care Inc., Bethlehem, PA, USA.*

FDA Label Image

Carton 2 (Carton 2ml)

Packaging label for Glycopyrrolate Injection, USP 0.4 mg/2 mL (0.2 mg/mL) solution for intramuscular or intravenous administration. The label includes warnings such as 'Not for use in newborns' and 'Contains benzyl alcohol.' Manufactured by Piramal Critical Care Inc. The carton holds 25 single-dose 2 mL vials.*

FDA Label Image

Vial 5 (Vial 5ml)

Label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) solution for intramuscular and intravenous use, labeled for use in newborns. The label states it contains benzyl alcohol as a preservative and 5 mL multiple dose vials. Manufactured for Piramal Critical Care Inc, Bethlehem, Pennsylvania, USA, with storage instructions at controlled room temperature 20 to 25°C and labeled as a product of India.*

FDA Label Image

Carton 5 (Carton 5ml)

Packaging label for Glycopyrrolate Injection, USP 1 mg/5 mL (0.2 mg/mL) injection solution. The label indicates the product contains benzyl alcohol and is for intramuscular or intravenous administration. It is presented in 25 vials of 5 mL multiple dose vials. Manufactured by Piramal Critical Care Inc, Bethlehem, PA, USA.*

FDA Label Image

Vial 20 (Vial 20ml)

Label for Glycopyrrolate Injection, USP, 0.2 mg/mL (4 mg/20 mL) in a 20 mL multiple dose vial. The label states it contains benzyl alcohol and is indicated for intramuscular or intravenous administration. Manufactured by Piramal Critical Care Inc, Bethlehem, PA, USA. The label includes storage instructions and cautions against use in newborns.*

FDA Label Image

Carton 20 (Carton 20ml)

Packaging label for Glycopyrrolate Injection, USP, 4 mg per 20 mL (0.2 mg/mL) solution for injection. The label states it is for intramuscular or intravenous administration and is not for use in newborns. The product contains benzyl alcohol and is supplied in 10 multiple dose vials of 20 mL each. Manufactured by Piramal Critical Care Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.